Study Explores Serum Glycoprotein 96 as Potential Biomarker for Psoriasis Diagnosis and Management

A recent study published in the *Archives of Dermatological Research* examines the potential role of serum glycoprotein 96 as a biomarker for psoriasis. Researchers Ömer Kaya, Mehmet H. Şehitoğlu, and Selim I. Mermutlu conducted the investigation to explore the connection between this glycoprotein and psoriasis, a chronic inflammatory skin condition. The findings suggest that serum glycoprotein 96 may hold significance in improving diagnostic and management strategies for individuals affected by the disease.

The study highlights the potential of serum glycoprotein 96 as a measurable indicator linked to psoriasis severity or progression. By analyzing its levels in patients with psoriasis, researchers aim to better understand its role in the condition’s underlying mechanisms. This research could contribute to advancements in identifying biomarkers that assist clinicians in diagnosing and monitoring psoriasis more effectively. Further studies are expected to build on these findings to determine how this protein might be integrated into clinical practice for managing the disease.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: January 23, 2026

Author

GOAI